# Nicotinic Receptors and Schizophrenia

> **NCT01400477** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 97 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** DMXB-A-SR
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01400477
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2019-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01400477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01400477, "Nicotinic Receptors and Schizophrenia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01400477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*